Saitama, Japan

Takeshi Hanada

This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Daiichi Sankyo Company, Limited, Other. Active years: 2014-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeshi Hanada. Retrieved from https://idiyas.com/inventor/takeshi-hanada-j0wsjumq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0



Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Hyogo, JP (2014)
  • Saitama, JP (2015)

Company Filing History:

goldMedal2 out of 463 
 
Daiichi Sankyo Company, Limited
 patents
silverMedal1 out of 834,659 
Other
 patents
where one patent can have more than one assignee

Years Active: 2014-2015

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Takeshi Hanada

Introduction

Takeshi Hanada is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of liquid preparations for physiologically active peptides. With a total of 2 patents, his work focuses on enhancing the bioavailability of important peptides used in medical applications.

Latest Patents

One of Hanada's latest patents is titled "Liquid preparation of physiologically active peptide." This invention provides an effective liquid formulation that achieves high bioavailability of physiologically active peptides or proteins, including ghrelins, when administered as drugs. The method also improves the bioavailability of these peptides when subcutaneously injected in aqueous solutions. The liquid preparation includes a physiologically active peptide, an acid solution, an alcohol, and a polar organic liquid.

Another significant patent is for a "Motilin-like peptide compound having transmucosal absorbability imparted thereto." This invention aims to provide motilin-like peptide compounds that maintain the gastrointestinal motility stimulating activity of native motilin while enhancing absorbability upon transmucosal administration. The motilin derivatives are designed to withstand degradation during absorption and maintain their physiological activity.

Career Highlights

Takeshi Hanada has worked with prominent companies, including Daiichi Sankyo Company, Limited. His experience in the pharmaceutical industry has allowed him to contribute to innovative solutions in peptide formulation and delivery.

Collaborations

Hanada has collaborated with notable coworkers such as Naomi Wakabayashi and Seiji Sato. Their combined expertise has likely contributed to the success of his inventions.

Conclusion

Takeshi Hanada's work in the field of biochemistry, particularly with his innovative patents, showcases his commitment to advancing medical science. His contributions are significant in improving the delivery and effectiveness of physiologically active peptides.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…